Short Interest in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Declines By 34.3%
MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA - Get Free Report) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totaling 19,177,371 shares, a decrease of 34.3% from the June 15th total of 29,201,925 shares. Approximately 7.5% of the shares of the company are sold short. Based on an average daily trading volume, of 7,120,957 shares, the days-to-cover ratio is currently 2.7 days.
NASDAQ:AKBA